HER2 activating mutations are targets for colorectal cancer treatment

Shyam M. Kavuri, Naveen Jain, Francesco Galimi, Francesca Cottino, Simonetta M. Leto, Giorgia Migliardi, Adam C. Searleman, Wei Shen, John Monsey, Livio Trusolino, Samuel A. Jacobs, Andrea Bertotti, Ron Bose

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'HER2 activating mutations are targets for colorectal cancer treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences